BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17341175)

  • 1. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].
    Harting I; Sellner J; Meyding-Lamadé U; Sartor K
    Rofo; 2003 May; 175(5):613-22. PubMed ID: 12743852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic identification of gray matter structures from MRI to improve the segmentation of white matter lesions.
    Warfield S; Dengler J; Zaers J; Guttmann CR; Wells WM; Ettinger GJ; Hiller J; Kikinis R
    J Image Guid Surg; 1995; 1(6):326-38. PubMed ID: 9080353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance spectroscopy in multiple sclerosis].
    Viala K; Stievenart JL; Cabanis EA; Lyon-Caen O; Tourbah A
    Rev Neurol (Paris); 2000 Dec; 156(12):1078-86. PubMed ID: 11139723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In-vivo assessment of multiple sclerosis pathology: the role of neuroimaging techniques].
    Comi G; Rovaris M; Filippi M
    Rev Neurol; 2000 Jun 16-30; 30(12):1218-23. PubMed ID: 10935254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.
    Coates T; Slavotinek JP; Rischmueller M; Schultz D; Anderson C; Dellamelva M; Sage MR; Gordon TP
    J Rheumatol; 1999 Jun; 26(6):1301-5. PubMed ID: 10381047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla.
    Kornguth S; Anderson M; Markley JL; Shedlovsky A
    Neuroimage; 1994 Jun; 1(3):220-9. PubMed ID: 9343573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.
    Zijdenbos AP; Forghani R; Evans AC
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1280-91. PubMed ID: 12585710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New non-invasive technique to visualize three-dimensional anatomical structures of myelinated white matter tracts of human brain in vivo.
    Kinosada Y; Nakagawa T
    Front Med Biol Eng; 1994; 6(1):37-49. PubMed ID: 8060903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
    Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM
    Ann Neurol; 2000 Mar; 47(3):391-5. PubMed ID: 10716264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of imaging in multiple sclerosis and white matter disease.
    Butman JA; Frank JA
    Neuroimaging Clin N Am; 2000 Nov; 10(4):669-87 ,viii. PubMed ID: 11359718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1,000 studies.
    Udupa JK; Nyúl LG; Ge Y; Grossman RI
    Acad Radiol; 2001 Nov; 8(11):1116-26. PubMed ID: 11721811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging.
    Makris N; Worth AJ; Sorensen AG; Papadimitriou GM; Wu O; Reese TG; Wedeen VJ; Davis TL; Stakes JW; Caviness VS; Kaplan E; Rosen BR; Pandya DN; Kennedy DN
    Ann Neurol; 1997 Dec; 42(6):951-62. PubMed ID: 9403488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T; Martínez-Yélamos A
    Rev Neurol; 2000 Jun 16-30; 30(12):1223-7. PubMed ID: 10935255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelinating diseases, leukodystrophies, and other myelin disorders.
    Suzuki K; Armao D; Stone JA; Mukherji SK
    Neuroimaging Clin N Am; 2001 Feb; 11(1):vii, 15-35. PubMed ID: 11331226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathogenesis of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
    De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL
    J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3D FSPGR (fast spoiled gradient echo) magnetic resonance imaging in the diagnosis of focal cortical dysplasia in children].
    Alikhanov AA; Sinitsyn VE; Perepelova EM; Mukhin KIu; Demushkina AA; Omarova MO; Piliia SV
    Vestn Rentgenol Radiol; 2001; (2):9-16. PubMed ID: 11503183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnetic resonance imaging of the brain in multiple sclerosis].
    Kharchenko VP; Krivenko EV; Nikiforuk NM
    Vestn Rentgenol Radiol; 1999; (2):4-8. PubMed ID: 12717894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.